Follow
Marta Quadri
Title
Cited by
Cited by
Year
A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE
JR Godin, P Roy, M Quadri, D Bagdas, W Toma, R Narendrula-Kotha, ...
Brain, behavior, and immunity 87, 286-300, 2020
412020
Dissection of N, N-diethyl-N′-phenylpiperazines as α7 nicotinic receptor silent agonists
M Quadri, RL Papke, NA Horenstein
Bioorganic & medicinal chemistry 24 (2), 286-293, 2016
392016
Bis (ammonio) alkane-type agonists of muscarinic acetylcholine receptors: Synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity
C Matera, L Flammini, M Quadri, V Vivo, V Ballabeni, U Holzgrabe, ...
European journal of medicinal chemistry 75, 222-232, 2014
372014
Cracking the betel nut: cholinergic activity of Areca alkaloids and related compounds
NA Horenstein, M Quadri, C Stokes, M Shoaib, RL Papke
Nicotine & Tobacco Research, 1-8, 2017
332017
Allosteric agonism of α7 nicotinic acetylcholine receptors
A Gulsevin, RL Papke, C Stokes, G Sumanta, GA Thakur, M Quadri, ...
Molecular Pharmacology, mol. 119.115758, 2019
26*2019
The antinociceptive and anti-inflammatory properties of the α7 nAChR weak partial agonist p-CF3 N, N-diethyl-N′-phenylpiperazine
M Quadri, D Bagdas, W Toma, C Stokes, NA Horenstein, MI Damaj, ...
Journal of Pharmacology and Experimental Therapeutics 367 (2), 203-214, 2018
242018
Macroscopic and microscopic activation of α7 nicotinic acetylcholine receptors by the structurally unrelated ago-PAMs B-973B and GAT107
M Quadri, S Garai, GA Thakur, C Stokes, A Gulsevin, NA Horenstein, ...
Society for Neuroscience, 2018
22*2018
Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine‐Δ2‐Isoxazoline Scaffold: Synthesis and …
M Quadri, C Matera, A Silnović, MC Pismataro, NA Horenstein, C Stokes, ...
ChemMedChem 12 (16), 1335-1348, 2017
192017
Sulfonium as a surrogate for ammonium: a new α7 nicotinic acetylcholine receptor partial agonist with desensitizing activity
M Quadri, C Stokes, A Gulsevin, ACJ Felts, KA Abboud, RL Papke, ...
Journal of medicinal chemistry 60 (18), 7928-7934, 2017
152017
Modification of the anabaseine pyridine nucleus allows achieving binding and functional selectivity for the α3β4 nicotinic acetylcholine receptor subtype
C Matera, M Quadri, M Sciaccaluga, DY Pomè, F Fasoli, M De Amici, ...
European Journal of Medicinal Chemistry 108, 392-405, 2016
152016
Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor …
MC Pismataro, NA Horenstein, C Stokes, M Quadri, M De Amici, ...
European journal of medicinal chemistry 205, 112669, 2020
142020
Selective agonists and antagonists of α9 versus α7 nicotinic acetylcholine receptors
RL Papke, H Andleeb, C Stokes, M Quadri, NA Horenstein
ACS chemical neuroscience 13 (5), 624-637, 2022
112022
Synthesis of saccharin-glycoconjugates targeting carbonic anhydrase using a one-pot cyclization/deprotection strategy
AB Murray, M Quadri, H Li, R McKenna, NA Horenstein
Carbohydrate research 476, 65-70, 2019
102019
Novel 5-(quinuclidin-3-ylmethyl)-1, 2, 4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation
M Quadri, A Silnović, C Matera, NA Horenstein, C Stokes, M De Amici, ...
European journal of medicinal chemistry 160, 207-228, 2018
102018
Silent agonists for α7 nicotinic acetylcholine receptors
RL Papke, M Quadri, A Gulsevin
Pharmacological Research 190, 106736, 2023
72023
Nicotinic acetylcholine receptor silent agonists
NA Horenstein, RL Papke, M Quadri
US Patent 10,662,191, 2020
22020
Determination of acid dissociation constants of poorly water-soluble nicotinic ligands by means of electrophoretic and potentiometric techniques
G Roda, C Dallanoce, V Gambaro, G Grazioso, V Liberti, C Matera, ...
PHARMACEUTICA ANALYTICA ACTA 6 (7), 1-5, 2015
22015
A convenient synthesis of 4-(2-hydroxyethyl) indolin-2-one, a useful intermediate for the preparation of both dopamine receptor agonists and protein kinase inhibitors
C Matera, M Quadri, S Pelucchi, M De Amici, C Dallanoce
Monatshefte für Chemie-Chemical Monthly 145, 1139-1144, 2014
22014
Nicotinic acetylcholine receptor silent agonists
NA Horenstein, RL Papke, M Quadri
US Patent App. 17/370,634, 2021
12021
Nicotinic acetylcholine receptor silent agonists
NA Horenstein, RL Papke, M Quadri
US Patent 11,155,551, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20